Commentary
Brodalumab and suicidal ideation in the context of a recent economic crisis in the United States

https://doi.org/10.1016/j.jaad.2015.08.057Get rights and content

References (9)

  • Papp K, Reich K, Leonardi C, et al. Efficacy and safety of brodalumab in patients with moderate to severe plaque...
  • National Center for Health Statistics. Underlying cause of death 1999-2013. Available from: URL:...
  • S. Tyring et al.

    Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomized phase III trial

    Lancet

    (2006)
  • K.A. Papp et al.

    Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicenter clinical trials

    Clin Drug Investig

    (2011)
There are more references available in the full text version of this article.

Cited by (0)

Funding sources: None.

Disclosure: Dr Kimball has been a consultant and investigator for Amgen, Abbvie, Janssen, Novartis, Celgene, and Pfizer; has been a consultant for Eli Lilly; and has fellowship funding from Janssen. Ms Danesh has no conflicts of interest to declare.

View full text
Copyright © 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.